This study aims to compare the prevalence of hypogonadism between male patients with early-onset type 2 diabetes mellitus (T2DM) and late-onset type 2 diabetes. A total of 122 male patients with early-onset T2DM (diagnosis age ≤40 years) and 100 male patients with late-onset T2DM (diagnosis age >40 years) were recruited from our in-patient department between 1 January 2013 and 28 December 2015. Serum FSH, LH, testosterone, lipid profile, uric acid, HbA1c, and beta-cell function were determined in blood samples. The diagnosis of hypogonadism was based on the levels of LH, FSH, and total testosterone. The mean onset age was 29.86 AE 6.31 and 54.47 AE 9.97 years old in the early-onset group and late-onset group, respectively. Compared with late-onset T2DM, those with early-onset T2DM had a higher proportion of new-onset diabetes, were more likely to be obese, and had worse glycemic control, lipid control, and lower sex hormone-binding globulin (SHBG). The prevalence of hypogonadism was much higher in the early-onset group than in the late-onset group (48.0% vs. 26.7%, p < 0.05). The rate of secondary hypogonadism in the earlyonset group and late-onset group were 44.3% and 25.0%, respectively (p < 0.05). Obesity, waist circumference, and SHBG were significantly associated with serum total testosterone level in all, early-onset, and late-onset T2DM. Both all and early-onset T2DM groups had positive correlations between total testosterone and fasting C-peptide, total cholesterol, triglycerides, and uric acid. Our results indicate that in a population of admission to a large urban hospital in China, the prevalence of hypogonadism was higher in the patients with early-onset T2DM than that of late-onset T2DM. This prevalence might be attributable to greater obesity, worse lipid control, and lower SHBG levels in those patients.
INTRODUCTION
The age of onset of type 2 diabetes is declining, and it has become a major concern for health care professionals. Recently, the JADE program reported that patients with early-onset diabetes had higher mean concentrations of HbA1c and low-density lipoprotein (LDL) cholesterol than those with late-onset diabetes (Yeung et al., 2014) . Early-onset T2DM was the more lethal phenotype of diabetes and was associated with a greater mortality, more diabetes complications, and more unfavorable cardiovascular disease risk factors when compared with T1DM (Pavkov et al., 2006; Constantino et al., 2013; Zhang & Ning, 2014) . It is important to clarify the clinical characteristics of early-onset T2DM and to find the potential risk factors for those patients.
Recently, the role of testosterone in the development of metabolic disorders has been observed, and many studies proved that low testosterone was associated with impaired insulin sensitivity, central obesity, dyslipidemia, and hypertension (Kupelian et al., 2008; Li et al., 2010; Zhang et al., 2015) ; metaanalysis documented that testosterone supplementation was not only to improve glycometabolic profile in those with metabolic disturbances, but also improve even body weight and waist circumference in T2DM (Corona et al., 2016a,b) ; on the other hand, much evidence has documented that obesity/metabolic diseases induces incident hypogonadism (Corona et al., 2012 (Corona et al., , 2015 . Hence, there is a bidirectional relationship between the two conditions. However, the age of male patients in those studies was usually between the fifth and seventh decades of life. Limited data were available on the prevalence of hypogonadism in earlyonset diabetes, and the function of hypothalamic-pituitary-gonadal (HPG) axis in patients with diabetes at different ages was also unclear. Early-onset T2DM with hypogonadism needs to be studied more, as this problem might affect the fertility of the patients throughout their reproductive years. Our study aims to investigate the prevalence of hypogonadism in male patients with early-onset type 2 diabetes requiring admission to a large urban hospital in China, and to compare the differences in HPG axis function between early-onset vs. late-onset T2DM.
MATERIALS AND METHODS

Patients
A total of 122 men with early-onset T2DM (onset ≤40 years of age) and 100 late-onset T2DM (onset >40 years of age) who were admitted to the Shanghai Tenth People's Hospital between January 2013 and December 2015 were recruited in our study. Eligibility criteria included (i) men 18-80 years of age; (ii) satisfied the 2014 definition and criteria for type 2 diabetes set by America Diabetes Association (American Diabetes Association, 2014). Exclusion criteria included (i) acquired hypogonadotropic hypogonadism; (ii) congenital hypogonadotropic hypogonadism; (iii) hyperthyroidism; (iv) ever having received testosterone replacement for a period of at last 6 months; (v) moderate or severe liver and renal dysfunction, including serum alanine aminotransferase of 120 IU/L, aspartate aminotransferase of 80 IU/L, and serum creatinine of 115 lmol/L. Hypogonadism was defined as serum total testosterone below 3.0 ng/mL Liu et al., 2013; Ho et al., 2015) . Primary hypogonadism was defined as LH or FSH >10 IU/L with total testosterone <3.0 ng/mL, while secondary hypogonadism was defined as LH or FSH ≤10 IU/L with total testosterone <3.0 ng/mL (Kapoor et al., 2007) . Duration of DM ≤2 years was defined as newly onset DM. The study protocol was approved by the Institutional Human Subjects Review Board of Shanghai Tenth People's Hospital, and all participants gave their informed consent.
Measurements
Age, age of onset, and duration of diabetes, family history, blood pressure, height, weight, and body mass index (BMI) were obtained. After 12 h of overnight fasting, laboratory test parameters were collected in the morning during the patients' admission, including total cholesterol (TC), triglyceride (TG), free fatty acid (FFA), high-density lipoprotein (HDL), low-density lipoprotein (LDL), follicle-stimulating hormone (FSH), luteinizing hormone (LH), testosterone, sex hormone-binding globulin (SHBG), leptin, glycosylated hemoglobin A1c (HbA1c), and fasting plasma glucose (glucose 0 min) and fasting C-peptide (C-peptide 0 min). LH, FSH, testosterone, and SHBG were tested by means of an immunochemiluminometric assay (Roche Diagnostics GmbH, Cot., Sandhofer, Mannheim, Germany). Serum leptin was measured in a solid-phase sandwich enzyme immunoassay (R&D Systems, Inc., Minneapolis, MN, USA). The standard mealload test (70 g of instant noodles equivalent to an energy intake of 500 kilocalories) was performed , followed in 120 min by examination of plasma glucose, insulin, and C-peptide. Free testosterone concentrations were calculated by Sartorius et al.'s formula, which has been widely adopted in the literature (Keelan et al., 2012; Cooper et al., 2015) .
Statistical analysis
Data were expressed as mean AE standard deviation (SD) for normal distribution, and expressed as median (upper and lower quartiles) for skewed distribution. Standard T test was used to compare the baseline morphometric measurements. Data of skewed deviations were compared by non-parametric test. Pearson's correlation analysis was used to investigate the relationship of two indices. Statistical Product and Service Solutions version 20 (SPSS Inc., Chicago, IL, USA) software were used for statistical analysis. A value of p < 0.05 was considered statistically significant.
RESULTS
General characteristics of patients with T2DM
The general features of patients with T2DM are shown in Table 1 . The mean onset age of early-onset diabetes was significantly different from late-onset ones. The duration of diabetes in the early-onset group was much shorter than that of late-onset group. The ratio of family history in the early-onset group was significantly higher than that of late-onset group. About 49.6% patients in the early-onset group were newly diagnosed with T2DM, and the percentage was much higher than that of lateonset group. Compared with patients with late-onset diabetes, those with early-onset diabetes had a higher percentage of obesity. Systolic and diastolic blood pressure had no significant differences between the two groups.
Sex hormone, glucose, and lipid parameters
Compared with patients with late-onset diabetes, those with early-onset diabetes had higher HbA1c and fasting glucose. However, fasting C-peptide, postprandial glucose, and C-peptide were no different in the two groups. Compared with the lateonset group, the early-onset group had severe dysfunction of lipid metabolism (total cholesterol and triglyceride). The level of leptin and inflammatory factors (uric acid and FFA) had no significant differences between the two groups. Although there were no significant differences in total and free testosterone in two groups, the prevalence of hypogonadism was 48.0% among early-onset patients and 26.7% among late-onset patients (p < 0.05). The rate of primary hypogonadism in the early-onset group and the late-onset group were 2.4% and 7.0%, respectively (p > 0.05), while the rate of secondary hypogonadism in the early-onset group and late-onset group were 44.3% and 25.0%, respectively (p < 0.05). The early-onset group had lower SHBG together with lower FSH and LH than the late-onset group (Table 2) . Correlations of total testosterone concentrations and predictors of hypogonadism As is shown in Table 3 , total serum testosterone concentration was negatively correlated with BMI, waist circumference, and positively associated with SHBG among three groups: all T2DM patients, early-onset T2DM patients, and late-onset T2DM patients. There was no correlation between total testosterone and HbA1c, LDL-c, FFA, SBP, or leptin for all or early-onset or late-onset T2DM patients. Both all and early-onset T2DM groups had positive correlations between total testosterone and fasting C-peptide, total cholesterol, triglycerides, uric acid, and had a negative correlation between total testosterone and duration. In the late-onset group, total testosterone was positively correlated with HDL-c.
DISCUSSION
The link between hypogonadism and diabetes has recently received substantial attention. Many observation studies have reported that male patients with diabetes were more likely to have low total testosterone level compared to non-diabetics (Dhindsa et al., 2004; Kapoor et al., 2007; Al Hayek et al., 2014) . However, limited information was available on the levels of testosterone among male patients with early-onset T2DM. The present study provided the first evidence that, in a population of admission to a large urban hospital in China, hypogonadism was more prevalent in the patients with early-onset type 2 diabetes compared to those with late-onset type 2 diabetes.
In our study, the mean age of the early-onset group was much younger than that of the late-onset group. Compared with patients with late-onset T2DM, those with early-onset T2DM had a strong family history and were more likely to be obese, consistent with finding from the JADE program (Yeung et al., 2014) . We also observed that the individuals with early-onset T2DM had worse glycemic and lipid control than the late-onset T2DM patients despite having a shorter duration of diabetes. These findings were consistent with previous studies in Asian countries (Zhang & Ning, 2014) . However, the underlying pathogenesis of the phenomenon was unclear. Genetic factors, socioeconomic, or psychological-behavioral contributions, such as increased stress, depressive problems, or poor self-management, coupled with a lower tendency to have a healthy lifestyle might be involved (Gregg et al., 2010; Hessler et al., 2011; Zhang & Ning, 2014) .
Growing evidences document that hypogonadism should be considered as a risk factor for metabolic syndrome, diabetes mellitus, and cardiovascular diseases in men (Kupelian et al., 2008; Li et al., 2010; Liu et al., 2013) . In our study, 48.0% of men with early-onset T2DM were considered to have hypogonadism compared with 26.7% of men with late-onset T2DM (p < 0.05). The percentage of hypogonadism in the late-onset group was comparable to previous studies which have the similar mean age and the same definition of hypogonadism (Liu et al., 2013; Al Hayek et al., 2014; Ho et al., 2015) . There was limited information about the prevalence of hypogonadism among men with early-onset T2DM. Only a few studies reported that the prevalence of hypogonadism in men with T2DM at the 31-40 years age group reported by others varied from 19.1% to 42% (Chandel et al., 2008; Ganesh et al., 2009; Al Hayek et al., 2014; Cooper et al., 2015) . The differences might be because of different characteristics of populations (ethnic, duration of T2DM, outpatient, or inpatient), the difference in the cut-off points used for testosterone, measurement variations, and small sample size.
It is interesting to note that although the average level of testosterone was comparable in early-onset and late-onset groups, the percentage of hypogonadism and secondary hypogonadism was much higher in early-onset group. The results indicate that patients with early-onset T2DM were more likely to have an inadequate release of gonadotropin. The high prevalence of hypogonadism in early-onset group was in contrast with those findings reached by others (Grossmann et al., 2008; Liu et al., 2013; Al Hayek et al., 2014) , while it was consistent with a smaller clinic-based study, showing the prevalence of hypogonadism was 24% in the 31-40 years age group and 12% in the 41-50 years age group (Ganesh et al., 2009) . A plausible explanation for this was that the increased obesity in the early-onset T2DM group would increase the conversion of testosterone into estradiol in the adipose tissue, causing an inhibition of the HPG axis (Vermeulen et al., 1993; Kapoor et al., 2007; Wang et al., 2011) . A high proportion of new-onset diabetes in the earlyonset group might be associated with this phenomenon, which was supported by some studies. Those studies demonstrated that a high prevalence of hypogonadism and sexual dysfunction were observed in newly onset diabetic population (Corona et al., 2013 (Corona et al., , 2014 . Higher levels of triglycerides, total cholesterol, and uric acid were negatively associated with total testosterone levels in the total population and in the early-onset group, but not in the late-onset group. Our results were generally consistent with previous epidemiological data (Wang et al., 2011; Liu et al., 2013; Mattack et al., 2015) . It was reported that testosterone replacement could improve the lipid profile of dyslipidemic men, yet the underlying causes for this phenomenon remain unclear (Corona et al., 2016b) . In our study, it seemed that the association between lipid profile and total testosterone concentrations were more obvious in the total population and the early-onset group than in the late-onset group, which implied that poor control of the lipid profile might contribute to a high prevalence of low testosterone in the early-onset group. However, there was no association between HbA1c and testosterone concentration among the three defined groups, which suggested that HbA1c was not a significant predictor of hypogonadism. This was supported by some studies (Grossmann et al., 2008; Ganesh et al., 2009; Al Hayek et al., 2014) , while it was in contradiction to those reached by others (Kapoor et al., 2007; Fukui et al., 2008) .
It has been reported that SHBG was a major determinant of clearance of sex hormones, and SHBG levels were strongly inversely associated with the risk of T2DM (Lakshman et al., 2010) . In our study, the mean serum SHBG levels of the early-onset group were much lower than those of the late-onset group. Consistent with previous studies, SHBG was positively associated with serum testosterone concentration (Dhindsa et al., 2004; Ho et al., 2015) . The phenomenon is probably a consequence of the higher waist circumference and worse glucose control in the early-onset group (Laaksonen et al., 2004; Grossmann et al., 2008) .
There are several limitations in this cross-sectional study. First, we did not assess the symptoms of hypogonadism in all patients. Second, the relative small case number might limit the power to detect a difference. Third, we could not follow-up the male patients with hypogonadism to separate the effect of a higher prevalence hypogonadism in early-onset group from the generally higher cardiometabolic risk factor burden among those individuals. More observational studies are required to confirm our findings.
CONCLUSION
In the population requiring admission to a large urban hospital in China, the incidence of hypogonadism was more prevalent in patients with early-onset T2DM than in those with late-onset T2DM, which might be explained by more obesity, worse lipid control, and low SHBG levels in patients with early-onset T2DM.
